ClinicalTrials.Veeva

Menu

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

U

University of Helsinki

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Atopic Dermatitis
Asthma
Allergic Conjunctivitis
Allergic Rhinitis, Seasonal
Food Hypersensitivity

Treatments

Drug: Mixture of probiotic bacteria and prebiotic oligosaccharide

Study type

Interventional

Funder types

Other

Identifiers

NCT00298337
T101060058 T1040A0002;T110612;

Details and patient eligibility

About

The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants

Sex

All

Ages

37 to 42 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • mother or father fo child with doctor diagnoses allergic disease

Exclusion criteria

  • prematurity, major malformations

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems